RECENT NEWS

A new type of blood test using lipids could make it easier to identify children at risk of complications around obesity including type two diabetes, liver and heart disease, say scientists.

A Liberal Democrats survey says one in four people have avoided calling an ambulance because they thought it would take too long to arrive.

Hundreds of babies have begun to be tested for over 200 rare genetic conditions as part of a world-leading study in NHS hospitals that aims to screen up to 100,000 newborns in England.

DrDoctor, a leading patient engagement platform (PEP) supplier, has announced a new partnership with Countess of Chester Hospital NHS Foundation to empower operational and clinical teams to manage and scale hybrid patient pathways within the trust.

​Tens of thousands of children and eligible adults living with type 1 diabetes across England are set to receive an ‘artificial pancreas’ thanks to cost-effective deals secured by the NHS with suppliers of the technology.

​A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that patients may benefit if doctors stop calling certain early-stage changes to the prostate 'cancer'.

Speaking at the Future Surgery event in London today, Tim Mitchell, President of the Royal College of Surgeons of England, warned the Government it will ‘fail to make a sufficient dent in reducing waiting times without investment in crumbling NHS infrastructure and new technology’.

Global leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR), committing to a clear set of targets and actions, including reducing the estimated 4.95 million human deaths associated with bacterial antimicrobial resistance (AMR) annually by 10% by 2030.

Around one in eight children aged between two and 10 in England are obese, an NHS survey has found.

A National Patient Safety Alert has been issued by the NHS England National Patient Safety team, endorsed by the Royal College of Obstetricians and Gynaecologists, Royal College of Midwives and Royal College of Anaesthetists, instructing all relevant NHS funded maternity care providers to cease pre-preparing oxytocin infusions at ward level in all clinical areas.

Diagnostic firm Cepheid has announced a new partnership with the Fleming Initiative, a global collaboration established by Imperial College Healthcare NHS Trust and Imperial College London to combat antimicrobial resistance (AMR).

People aged 16 and over who receive routine blood tests when they attend Sheffield’s Northern General Hospital A&E department are to be tested for HIV, hepatitis B and hepatitis C, regardless of symptoms, as part of a new Government scheme, unless they choose to opt out.

New resources including support for victims and survivors of sexual misconduct by doctors have been published by the General Medical Council (GMC).

NHS Western Isles (which is part of NHS Scotland) has collaborated with long-standing partner, Canon Medical Systems UK, to help ‘reduce the need for travel’ under the ‘Sustainable Travel’ initiative – one of five main drivers in NHS Scotland’s net-zero ambitions, as set out in the Climate Emergency and Sustainability Strategy (2022-2026).

Ondine Biomedical and Mölnlycke Health Care have announced a strategic partnership to bring Ondine’s Steriwave nasal decolonisation technology to the United Kingdom, EU, and Middle East markets.

A 6-bed discharge lounge and 5-bed palliative care ward have been created in a new facility at the Queen Elizabeth Hospital in King’s Lynn by MTX Contracts, using modern methods of construction (MMC) to deliver the build within timescales supporting RAAC recovery work at the hospital.

A BBC report has highlighted that failure to offer patients local or general anaesthesia while undergoing hysteroscopy, is resulting in experiences of extreme pain and trauma.

A Company Chemists’ Association (CCA) report urges the NHS to commission a community pharmacy diabetes screening service which would save the NHS £50m in recurring costs each year.

A new survey from Abbott shows that leading infectious disease experts around the world believe significant gaps remain in building surveillance programmes to identify emerging pathogens, public health funding and having adequate testing infrastructure capabilities.

Dartford and Gravesham NHS Trust has partnered with Better and Alcidion to successfully roll out the Better Meds electronic prescribing and medicine management (EPMA) system, and integrate it into the trust’s EPR system provided by Alcidion.